194093-42-0 Usage
Uses
Used in Endocrinology:
Cimaglermin is utilized as a treatment for growth hormone deficiency, a condition characterized by insufficient levels of growth hormone in the body. Its agonistic action on the growth hormone secretagogue receptor helps to increase growth hormone levels, thereby addressing the deficiency.
Used in Treatment of Cachexia:
Cimaglermin is also applied in the management of cachexia, a severe wasting disorder often associated with chronic diseases such as cancer and AIDS. By enhancing growth hormone release, it can potentially improve muscle mass and overall body composition in cachectic patients.
Used in Cardiology:
In the field of cardiology, Cimaglermin has been investigated for its potential to improve cardiac function and promote repair of tissue damage subsequent to a heart attack. The growth hormone release induced by Cimaglermin may contribute to the enhancement of heart function and regeneration of damaged cardiac tissue.
Ongoing research continues to explore the applications of N-[(8R)-1-azabicyclo[2.2.2]oct-8-yl]-2-oxo-9-thia-5-azabicyclo[4.3.0]nona-3,7,10-triene-3-carboxamide hydrochloride in various medical fields, with a focus on its therapeutic potential in endocrinology and cardiology.
Check Digit Verification of cas no
The CAS Registry Mumber 194093-42-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,4,0,9 and 3 respectively; the second part has 2 digits, 4 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 194093-42:
(8*1)+(7*9)+(6*4)+(5*0)+(4*9)+(3*3)+(2*4)+(1*2)=150
150 % 10 = 0
So 194093-42-0 is a valid CAS Registry Number.
InChI:InChI=1/C15H17N3O2S.ClH/c19-13-10(7-16-11-3-6-21-14(11)13)15(20)17-12-8-18-4-1-9(12)2-5-18;/h3,6-7,9,12H,1-2,4-5,8H2,(H,16,19)(H,17,20);1H/t12-;/m0./s1
